天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Welcome to chemicalbook!
+1 (818) 612-2111
Inquriy
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >Biochemical Engineering>Inhibitors>Acalabrutinib
Acalabrutinib
  • Acalabrutinib
  • Acalabrutinib
  • Acalabrutinib
  • Acalabrutinib
  • Acalabrutinib

Acalabrutinib NEW

Price Get Latest Price
Package 1Kg/Bag 25Kg/Bag 100Kg/Bag
Min. Order: 1Kg/Bag
Supply Ability: 20 tons
Update Time: 2024-12-23

Product Details

Product Name: Acalabrutinib CAS No.: 1420477-60-6
EC-No.: 814-272-0 Min. Order: 1Kg/Bag
Purity: 0.99 Supply Ability: 20 tons
Release date: 2024/12/23

Product Information 


NameAcalabrutinib
Other names

Acalabrutinib

1420477-60-6

ACP-196

Calquence

Acalabrutinib (ACP-196)

CAS number1420477-60-6
Molecular FormulaC26H23N7O2
Molecular Weight465.51
EINECS814-272-0


Acalabrutinib is a novel anti-cancer drug and a second generation Bruton's tyrosine kinase (BTK) inhibitor developed by Acerta Pharma. It is more potent and selective (fewer side-effects) than ibrutinib, the first-in-class BTK inhibitor. In October 2017, the Food and Drug Administration approved the drug for treatment of mantle cell lymphoma in patients who had previously been treated with another therapy.


Article illustration

Application 


Drug Indication
Acalabrutinib is an orally available inhibitor of Bruton's tyrosine kinase (BTK) with potential antineoplastic activity. Upon administration, acalabrutinib inhibits the activity of BTK and prevents the activation of the B-cell antigen receptor (BCR) signaling pathway. This prevents both B-cell activation and BTK-mediated activation of downstream survival pathways. This leads to an inhibition of the growth of malignant B cells that overexpress BTK. BTK, a member of the src-related BTK/Tec family of cytoplasmic tyrosine kinases, is overexpressed in B-cell malignancies; it plays an important role in B lymphocyte development, activation, signaling, proliferation and survival.
 
Formulations/PreparationsTablet
Powder for Suspension
Tablet, Chewable
Tablet, Extended Release
Capsule

Company Information 

Article illustration


Company Profile Introduction

Sinoway Industrial co., ltd. was established in 1987 in Xiamen, China, and now has been a leading group specialized in research, development, custom manufacturing and trading of pharmaceutical intermediates, APIs, health and food supplements, cosmetic raw materials, herbal extracts, polypeptides and prostaglandin derivatives, etc.. We have passed ISO9001:2015. With qualified products, competitive price and excellent service, we have received great reputation of our customers from all over the world, including Southeast Asia, Europe, North America, South America, Middle East and other countries. We have over 20 years good partners in Japan、Korea and Switzerland. Sinoway has a professional R&D team. We have built close cooperative relationships with many research institutes and universities in China. Moreover, Sinoway combines market analysis with technology, providing new business trends to our clients. In addition, we have very close cooperation relationships with many Chinese pharmaceutical factories. These pharmaceutical manufacturers have GMP regulated workshops, advanced production and testing equipments, first-class QC labs and a production team with rich experience. We can supply various Active Pharmaceutical Ingredients and finished products which meet EP/USP/BP standards. Chinese GMP, EU-GMP, COS/CEP certificates with DMF documents are available, and many products have been approved by FDA. We believe that quality and innovation are vital for an enterprise. Adhering to the business philosophy of integrity and win-win cooperation, Sinoway is looking forward to have a bright future with you together.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$0.00/1g
VIP1Y
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
2024-12-12
$39.00/5mg
VIP5Y
TargetMol Chemicals Inc.
2024-11-18
$0.00/10g
VIP1Y
Cangzhou Kangrui Pharma Tech Co. Ltd.,
2024-10-18
$1.00/1g
VIP1Y
Apeloa production Co.,Limited
2024-06-11
$0.00/1g
VIP2Y
shandong perfect biotechnology co.ltd
2023-08-02
$30.00/1kg
Henan Bao Enluo International TradeCo.,LTD
2023-07-31
$0.00/1KG
VIP3Y
Wuhan Senwayer Century Chemical Co.,Ltd
2022-11-07
$15.00/1KG
Zhuozhou Wenxi import and Export Co., Ltd
2021-07-10
$20.00/1KG
Longyan Tianhua Biological Technology Co., Ltd
2020-10-27
$1.00/1kg
Hebei Jimi Trading Co., Ltd.
2019-03-28
  • Since: 1996-07-16
  • Address: Fujian China ,16F, Huicheng Comm. Complex, 839 Xiahe RD.
INQUIRY